Lack of Disparity in Lower Urinary Tract Symptom Severity Between Community-Dwelling Non-Hispanic White, Mexican-American, and African-American Men

Urology

Volumn 69, Issue 4, 2007, Pages 697-702

  Markland, Alayne D ^a,b   Thompson, Ian M ^c,d   Ankerst, Donna P ^c,d   Higgins, Betsy ^c,d   Kraus, Stephen R ^b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; ARTICLE; BODY MASS; COMMUNITY CARE; COMMUNITY LIVING; CONTROLLED STUDY; DATA COLLECTION METHOD; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROPEAN AMERICAN; FAMILY HISTORY; HISPANIC; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MEXICAN AMERICANS; MIDDLE AGED; PROSTATISM; SEVERITY OF ILLNESS INDEX;

EID: 34147121652     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.024     Document Type: Article

References (20)

1. Jacobsen S.J., Girman C.J., and Lieber M.M. Natural history of benign prostatic hyperplasia. Urology 58 6 suppl 1 (2001) 5-16
2. Girman C.J., Jacobsen S.J., Tsukamoto T., et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 51 (1998) 428-436
3. Roberts R.O., Chute C.G., Rhodes T., et al. Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior. Urology 43 (1994) 621-628
4. Jacobsen S.J., Girman C.J., Guess H.A., et al. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol 155 (1996) 595-600
5. Sarma A.V., Wei J.T., Jacobson D.J., et al. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology 61 (2003) 1086-1091
6. Joseph M.A., Harlow S.D., Wei J.T., et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 157 (2003) 906-914
7. Rule A.D., Lieber M.M., and Jacobsen S.J. Is benign prostatic hyperplasia a risk factor for chronic renal failure?. J Urol 173 (2005) 691-696
8. Rule A.D., Jacobson D.J., Roberts R.O., et al. The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. Kidney Int 67 (2005) 2376-2382
9. McConnell J.D., Roehrborn C.G., Bautista O.M., et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349 (2003) 2387-2398
10. Clase C.M., Garg A.X., and Kiberd B.A. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13 (2002) 1338-1349
11. Harris M.I., Flegal K.M., Cowie C.C., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21 (1998) 518-522
12. Ifudu O., Dawood M., Iofel Y., et al. Delayed referral of black, Hispanic, and older patients with chronic renal failure. Am J Kidney Dis 33 (1999) 728-733
13. Barry M.J., Fowler Jr. F.J., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148 (1992) 1549-1557
14. Badia X., Garcia-Losa M., Dal-Re R., et al. Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. Urology 52 (1998) 614-620
15. Rhodes T., Girman C.J., Jacobsen S.J., et al. Does the mode of questionnaire administration affect the reporting of urinary symptoms?. Urology 46 (1995) 341-345
16. Roehrborn C.G., Boyle P., Gould A.L., et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53 (1999) 581-589
17. Platz E.A., Kawachi I., Rimm E.B., et al. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 163 (2000) 490-495
18. Hsu C.Y., Lin F., Vittinghoff E., et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14 (2003) 2902-2907
19. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 170 (2003) 530-547
20. Badia X., Rodriguez F., Carballido J., et al. Influence of sociodemographic and health status variables on the American Urological Association symptom scores in patients with lower urinary tract symptoms. Urology 57 (2001) 71-77